Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy
AUTOR(ES)
Thackray, Alana M.
FONTE
American Society for Microbiology
RESUMO
Young adult mice were inoculated with herpes simplex virus type 2 (HSV-2) in the ear pinna. A relatively severe infection resulted, and 45% of the mice died by 11 days postinfection. Therapy at 1 mg/ml by means of the drinking water with either famciclovir for periods of 5 or 10 days or valaciclovir for 5, 10, 15, or 20 days decreased clinical signs and reduced mortality to 15% or less. Throughout a period of 27 days, mice were tested daily for the presence of infectious virus in the ear pinna, brain stem, and ipsilateral trigeminal ganglia. Virus was cleared from these tissues in surviving, untreated animals by 12 days postinfection, and no infectious virus was detected subsequently in any tissue. Furthermore, no infectious virus was detected after day 9 in mice that had been treated with famciclovir. In mice that had received valaciclovir therapy, however, infectious virus was repeatedly detected in the trigeminal ganglia and brain stem tissue samples up to 7 days after treatment was discontinued. To date, no specific mechanism to account for these results has been discovered; however, possible mechanisms for the persistence of potentially infectious virus in neural tissue of treated mice are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89634Documentos Relacionados
- Antiviral Effect of Pyran Against Systemic Infection of Mice with Herpes Simplex Virus Type 2
- Selective spread of herpes simplex virus in the central nervous system after ocular inoculation.
- Chemotherapy of Genital Herpes Simplex Virus Type 2 Infections of Female Hamsters
- Xylotubercidin against herpes simplex virus type 2 in mice.
- Neurological involvement in mice after infection with a cold-adapted herpes simplex type 2 virus.